180 related articles for article (PubMed ID: 23361583)
1. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
[TBL] [Abstract][Full Text] [Related]
2. Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol.
Pappu AS; Connor WE; Merkens LS; Jordan JM; Penfield JA; Illingworth DR; Steiner RD
J Lipid Res; 2006 Dec; 47(12):2789-98. PubMed ID: 16983147
[TBL] [Abstract][Full Text] [Related]
3. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
Keller RK; Arnold TP; Fliesler SJ
J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
[TBL] [Abstract][Full Text] [Related]
4. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
5. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
Kolf-Clauw M; Chevy F; Ponsart C
J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model.
Gaoua W; Wolf C; Chevy F; Ilien F; Roux C
J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785
[TBL] [Abstract][Full Text] [Related]
7. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
[TBL] [Abstract][Full Text] [Related]
9. Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol.
Chambers CM; McLean MP; Ness GC
Am J Med Genet; 1997 Jan; 68(3):322-7. PubMed ID: 9024567
[TBL] [Abstract][Full Text] [Related]
10. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
11. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
12. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Xu L; Sheflin LG; Porter NA; Fliesler SJ
Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome.
Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C
Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS
Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
[TBL] [Abstract][Full Text] [Related]
16. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
Fliesler SJ; Xu L
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
[TBL] [Abstract][Full Text] [Related]
17. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
19. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
[TBL] [Abstract][Full Text] [Related]
20. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]